🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Non-Helium Magnetoencephalography in Pediatric Refractory Epilepsy

Recruitingn/aAges 3 Years - 18 YearsAllGuangzhou Women and Children's Medical Center
NCT07064421 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to evaluate the effectiveness of Magnetoencephalography (MEG) in the preoperative assessment of children with refractory epilepsy, particularly in identifying the seizure focus, and to compare it with the gold standard methods of Stereo-electroencephalography (SEEG) and Electrocorticography (ECoG). The main questions this study aims to answer are: 1. How consistent is MEG with SEEG/ECoG in locating the epileptic focus in children with refractory epilepsy? 2. What is the clinical efficacy of MEG in identifying epileptic foci? Participants will: 1. Be divided into 2 groups: the case group and the control group. Participants in the case group will undergo both MEG and SEEG/ECoG for preoperative assessment, while patients in the control group will undergo only SEEG/ECoG before surgery. 2. Be followed up at 1, 3, 6, and 12 months after surgery to as

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age range: 3-18 years old; 2. Clinically diagnosed with refractory epilepsy; 3. Capable of cooperating with magnetoencephalography evaluation and recording. Exclusion Criteria: 1. Patients with serious comorbidities or neurological or psychiatric disorders that affect magnetoencephalography examination. 2. Patients using drugs that affect central nervous system function; 3. Patients who are not suitable for surgical procedures; 4. Patients with progressive neurological disorders.
💊

What it tests

  • Magnetoencephalography plus Stereo-electroencephalography/Electrocorticography
  • Stereo-electroencephalography/Electrocorticography
📍

Where

1 site
Guangzhou Women and Children's medical center
Guangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy